Immune Responses After COVID-19 Booster Vaccination in Patients With Systemic Autoimmune Diseases
Researchers assessed immune responses among patients with systemic autoimmune diseases following receipt of a COVID-19 vaccine booster dose.
Researchers assessed immune responses among patients with systemic autoimmune diseases following receipt of a COVID-19 vaccine booster dose.
For patients with SLE, the risk for breakthrough COVID-19 infection is lower among those who have received a booster vaccine dose after initial vaccination.
The aim of the study was to determine the characteristics associated with severe COVID-19 outcomes among patients with systemic lupus erythematosus
Investigators conducted a systemic review to assess the effects of various medications on seroconversion rates following SARS-CoV-2 vaccination in patients with immune mediated inflammatory disease.
Investigators assessed the role of cell-mediated immunity in the development of cytomegalovirus infection in patients with systemic lupus erythematosus undergoing treatment with immunosuppressants.
Researchers conducted serum metabolomic analysis to see if ApoB:ApoA1 ratio is an accurate biomarker of cardiovascular disease risk in patients with juvenile systemic lupus erythematosus.
In this case study, the authors highlighted the importance of tuberculous arthritis in the differential diagnoses of patients with persistent ankle swelling.
Researchers evaluated the frequency of polyautoimmunity and its associated factors in a large retrospective cohort of patients with systemic lupus erythematosus.
The researchers aimed to describe the incidence of bacteremia in patients with SLE, and identify risk factors.
Prevalence of HPV infection increases in women with systemic lupus erythematosus, according to a 3-year follow-up study.